Glyburide

transient receptor potential cation channel subfamily M member 4 ; Homo sapiens







15 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33463481 ATP-sensitive Potassium Channel Subunits in Neuroinflammation: Novel Drug Targets in Neurodegenerative Disorders. 2022 2
2 33028147 Cerebrovascular effects of glibenclamide investigated using high-resolution magnetic resonance imaging in healthy volunteers. 2021 Jun 2
3 33080394 The antidiabetic drug glibenclamide exerts direct retinal neuroprotection. 2021 Mar 1
4 31936452 Role of Sulfonylurea Receptor 1 and Glibenclamide in Traumatic Brain Injury: A Review of the Evidence. 2020 Jan 9 1
5 31288831 Glibenclamide in aneurysmatic subarachnoid hemorrhage (GASH): study protocol for a randomized controlled trial. 2019 Jul 9 1
6 31623469 BIIB093 (IV glibenclamide): an investigational compound for the prevention and treatment of severe cerebral edema. 2019 Dec 1
7 30147301 Profile of intravenous glyburide for the prevention of cerebral edema following large hemispheric infarction: evidence to date. 2018 2
8 28740332 A Protective Role of Glibenclamide in Inflammation-Associated Injury. 2017 1
9 28877214 Direct versus indirect actions of ghrelin on hypothalamic NPY neurons. 2017 2
10 25749474 Glibenclamide for the treatment of ischemic and hemorrhagic stroke. 2015 Mar 4 1
11 24380477 Effect of glibenclamide on the prevention of secondary brain injury following ischemic stroke in humans. 2014 Jan 2
12 24671831 Exploratory analysis of glyburide as a novel therapy for preventing brain swelling. 2014 Aug 1
13 24834370 The Sur1-Trpm4 Channel in Spinal Cord Injury. 2013 Aug 17 1
14 21565835 Transient receptor potential melastatin 4 inhibition prevents lipopolysaccharide-induced endothelial cell death. 2011 Sep 1 2
15 18297105 9-phenanthrol inhibits human TRPM4 but not TRPM5 cationic channels. 2008 Apr 1